Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml
Ornstein, David K, Rayford, Walter, Fusaro, Vincent A, Conrads, Thomas P, Ross, Sally J, Hitt, Ben A, Wiggins, Wesley W, Veenstra, Timothy D, Liotta, Lance A, Petricoin, 3rd, Emanuel F
Published in The Journal of urology (01.10.2004)
Published in The Journal of urology (01.10.2004)
Get more information
Journal Article